Propanc Biopharma, Inc. (PPCB)

NASDAQ: PPCB · Real-Time Price · USD

0.5075

+0.0065 (1.30%)

At close: Oct 2, 2026, 4:00 PM EDT

0.5068

-0.0007 (-0.14%)

After-hours: Oct 2, 2026, 7:59 PM EDT

Propanc Biopharma Balance Sheet

Financials in millions USD. Fiscal year is July - June.

Millions USD. Fiscal year is Jul - Jun.

Assets

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022
Cash & Equivalents	0.83	0.01	0.02	0.01	0
Cash & Short-Term Investments	0.83	0.01	0.02	0.01	0
Cash Growth	6782.91%	-42.67%	109.86%	147.04%	80.36%
Other Receivables	0.01	0.01	0	0	0
Receivables	0.01	0.01	0	0	0
Prepaid Expenses	7.66	8.33	-	0.01	0.01
Other Current Assets	0.03	0	0	-	-
Total Current Assets	8.54	8.35	0.03	0.02	0.02
Property, Plant & Equipment	0.04	0.06	0.02	0.04	0.06
Long-Term Deferred Charges	-	0.29	0.03	-	-
Other Long-Term Assets	4.19	10.93	0	0	0
Total Assets	12.78	19.63	0.07	0.06	0.08

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022
Accounts Payable	1.13	1.25	1.21	0.97	0.94
Accrued Expenses	1.74	2.35	1.53	1.21	0.94
Short-Term Debt	0.46	1.56	0.87	0.51	0.98
Current Portion of Leases	0.02	0.02	0.02	0.02	0.02
Other Current Liabilities	-	0.4	0.16	0.45	0.18
Total Current Liabilities	3.35	5.58	3.79	3.16	3.06
Long-Term Debt	-	0.11	0.06	-	-
Long-Term Leases	0.02	0.04	-	0.02	0.04
Total Liabilities	3.38	5.73	3.85	3.18	3.11

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022
Common Stock	0	0	0	0.01	0
Additional Paid-In Capital	152.75	138.25	61.7	60.31	57.36
Retained Earnings	-144.48	-125.62	-66.7	-64.68	-61.56
Treasury Stock	-0.05	-0.05	-0.05	-0.05	-0.05
Comprehensive Income & Other	1.18	1.32	1.27	1.29	1.21
Total Common Equity	9.4	13.91	-3.78	-3.12	-3.03
Shareholders' Equity	9.4	13.91	-3.78	-3.12	-3.02
Total Liabilities & Equity	12.78	19.63	0.07	0.06	0.08

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022
Total Debt	0.51	1.73	0.95	0.55	1.04
Net Cash (Debt)	0.32	-1.71	-0.93	-0.54	-1.04
Net Cash Growth	-	-	-	-	-
Net Cash Per Share	0.29	-10.80	-	-	-
Filing Date Shares Outstanding	6.33	0.51	-	-	-
Total Common Shares Outstanding	3.31	0.46	-	-	-
Working Capital	5.19	2.77	-3.77	-3.14	-3.05
Book Value Per Share	2.84	29.94	-	-	-
Tangible Book Value	9.4	13.91	-3.78	-3.12	-3.03
Tangible Book Value Per Share	2.84	29.94	-	-	-
Machinery	0.03	0.03	-	0.03	0.03